A population-based study of the incidence, cause, and severity of anaphylaxis in the United Kingdom.
about
Glucocorticoids for the treatment of anaphylaxisGlucocorticoids for the treatment of anaphylaxisAdrenaline (epinephrine) for the treatment of anaphylaxis with and without shockAdrenaline for the treatment of anaphylaxis with and without shockH1-antihistamines for the treatment of anaphylaxis with and without shockH1-antihistamines for the treatment of anaphylaxis with and without shockSerious shortcomings in the management of children with anaphylaxis in Scottish schoolsMonovalent inactivated split-virion AS03-adjuvanted pandemic influenza A (H1N1) vaccine.Exploiting the potential of routine data to better understand the disease burden posed by allergic disorders.The use of syndromic surveillance to monitor the incidence of arthropod bites requiring healthcare in England, 2000-2013: a retrospective ecological study.Perspectives on anaphylaxis epidemiology in the United States with new data and analyses.Knowledge of anaphylaxis among Emergency Department staff.Anaphylaxis: mechanisms and management.Epidemiology of life-threatening and lethal anaphylaxis: a review.Emergency treatment of anaphylaxis in infants and children.Anaphylaxis associated with the vaccine against measles, mumps and rubella.Epidemiology and risk factors for drug allergy.Recognition and management of food-induced anaphylaxis.Anaphylaxis in Latin America: a report of the online Latin American survey on anaphylaxis (OLASA).Eight years of severe allergic reactions in Finland: a register-based report.Management of acute allergic reactions by dispatching physicians in a Medical Emergency Dispatch CentreSevere allergic reaction: management of anaphylaxis in hospital.Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.Incidence of food anaphylaxis in people with food allergy: a systematic review and meta-analysis.Symptom profile and risk factors of anaphylaxis in Central Europe.Suicide risk linked with clinical consultation frequency, psychiatric diagnoses and psychotropic medication prescribing in a national study of primary-care patients.Survey of the use of epinephrine (adrenaline) for anaphylaxis by junior hospital doctors.Recognition and treatment of anaphylaxis in the community.Recognition and treatment of anaphylaxis in hospital.Allergic reactions in the community: a questionnaire survey of members of the anaphylaxis campaign.Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England.Incidence of anaphylaxis in the city of Alcorcon (Spain): a population-based study.Epidemiology and disease burden from allergic disease in Scotland: analyses of national databases.Increasing trends of anaphylaxis-related events: an analysis of anaphylaxis using nationwide data in Taiwan, 2001-2013
P2860
Q24200443-022E15C2-65CA-4959-9EEF-F03BCAA11B96Q24236588-A0C6CE21-8761-497E-B82F-D26746103B5EQ24241174-6D21897D-506C-419E-B162-95DFDEB399CDQ24243567-B1782C0C-1311-4D44-8F0D-F486FAB9A645Q24245913-0A5F4A93-DF92-4EDE-9B32-27C904C766E9Q24246206-7C3E86AD-9E86-4890-A163-475AF95A6ECCQ28469039-5FA03041-28BC-4F50-9D53-8D021E64AA79Q30396654-F6D6CF2D-AC95-4B6F-B0B7-0F34E8218F9DQ31048676-663E4781-6B19-4755-96B1-E9364F4C90A0Q31074270-737390CF-9712-4B44-A7FA-056D3E86854EQ33736062-04664161-85E2-4BEB-A964-6A48FBEA1A83Q33974484-D5D1D35F-1037-47C5-BF80-3F5A44F31413Q34192100-B7FA8C96-EBE6-40BF-A0F7-A62134E269FEQ34396941-755F0BC1-7ADE-4ECC-8EC6-61C3C9A05D42Q34593489-4424B082-096A-4160-B7FD-D4CE93000994Q34618249-DAD7A2C6-323B-4AAD-8FA8-63717E9B10FBQ34976470-850E0738-F227-4D0F-B679-DF5F0ED4CA90Q34986991-A67CE45C-0162-4156-94D6-1FE468407D21Q35087159-7FC57CED-7B3B-47E1-9ED0-086F074B948FQ36834435-77CAA599-6A48-4672-AA69-4DDF30B990F5Q36916427-89F0C3FF-D11A-4672-AC26-52D1E65E651EQ37139131-D6E97F4A-DCED-4CF3-ACB4-8ECD38AB605FQ37873485-0E4EFD20-5615-459E-B90A-70CA48CFCCF4Q38286302-91AF94DF-0CC3-4E00-9999-8C8F5CC9B2FFQ39652242-5317BA54-94B2-4C1D-B308-28A1C0C9EEDDQ40572847-DE675B92-D6CD-450A-9375-982741A00707Q42136066-29954859-160B-4AD7-B57C-29339B61ABF4Q44320134-F113F3AD-2DBC-4C4A-A762-76D75B56ED0AQ45572168-BE558447-26AF-4A01-BA70-8B886ACC8652Q46559689-734818F6-412C-414F-B94F-F152129F9F13Q51114815-F113BEBF-E452-4178-A4A0-5835FAB4BF1CQ51353311-13707CBD-C4BB-4C19-9891-E6F0B9873C9EQ55647679-FCF4B295-011F-43A0-8703-AE1DB591E24AQ57816388-DF457179-6391-4F00-9E24-AA0407AB1046
P2860
A population-based study of the incidence, cause, and severity of anaphylaxis in the United Kingdom.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
A population-based study of th ...... hylaxis in the United Kingdom.
@en
A population-based study of th ...... hylaxis in the United Kingdom.
@nl
type
label
A population-based study of th ...... hylaxis in the United Kingdom.
@en
A population-based study of th ...... hylaxis in the United Kingdom.
@nl
prefLabel
A population-based study of th ...... hylaxis in the United Kingdom.
@en
A population-based study of th ...... hylaxis in the United Kingdom.
@nl
P1476
A population-based study of th ...... hylaxis in the United Kingdom.
@en
P2093
Michael M Peng
P304
P356
10.1001/ARCHINTE.164.3.317
P407
P50
P577
2004-02-01T00:00:00Z